The product contains hemoglobin molecules from expired donor blood, which are encapsulated in protective lipid shells.

World- First Discovery by Sydney Scientists Reveals the Hidden Cause of Organ Damage in COVID-19 and Other Deadly ConditionsAustralian researchers ...

By reprogramming brain cells, a new gene therapy approach for Alzheimer's developed by UC San Diego researchers could address ...

Researchers at Stanford have developed a new technology for removing blood clots that is more than twice as effective as ...

Is red light therapy the holy grail of holistic health remedies, or is it a scam? I took a deep dive to discover the benefits ...

Vitamin B12, or cobalamin, is crucial for energy production, nerve health, and a robust immune system. It boosts white blood ...

A Falmouth teen, Jayden Wilsey, is the first to receive gene therapy to treat sickle cell at Boston Children's Hospital.

Paris: Sanofi has received orphan drug designation from the US Food and Drug Administration (FDA) for rilzabrutinib, a novel, ...

US FDA grants orphan drug designation to Sanofi’s rilzabrutinib to treat sickle cell disease: Paris Thursday, June 5, 2025, 11:00 Hrs [IST] The US Food and Drug Administration ( ...

When treating an ischemic stroke – where a clot is blocking the flow of oxygen to the brain – every minute counts.

Rilzabrutinib granted orphan drug designation in the US for sickle cell disease <li /> Fourth orphan drug designation for rilzabrutinib ...

Over the past five or 10 years, methylene blue has come to be touted online as a so-called nootropic agent – a substance that ...